This study, sponsored by Region Örebro County, aims to establish ddPCR as a diagnostic tool for assessing bacterial load in septic patients, potentially leading to improved clinical outcomes and antibiotic stewardship. The high mortality rates associated with sepsis underscore the urgent need for innovative diagnostic solutions. If successful, this approach could position ddPCR as a valuable asset in critical care settings, enhancing the competitive landscape against traditional blood culture methods. The findings may also attract interest from pharmaceutical companies focused on antibiotic development and sepsis management, highlighting a significant market opportunity in the diagnostics and therapeutics space.